Showing posts with label সর্বশেষ. Show all posts
Showing posts with label সর্বশেষ. Show all posts

Saturday, 11 July 2020

Corona said the cause of death

Corona said the cause of death

Many are commenting that the novel coronavirus is getting weaker than before. The number of deaths due to the new virus is also decreasing.

Explaining the reason, Indian cardiologist Kunal Sarkar said, "Looking at a few incidents, this issue cannot be emphasized." However, reading the history of the epidemic, it is known that after attacking people for a few months, the mortality rate decreases as our body somewhat compromises with the deadly power of germs.

However, he said that if the power of the epidemic virus is underestimated, the rules and regulations should be lifted.

Ashok Sengupta, a lung specialist in India, said it was not time to test the potential for the Kovid-19 virus. If Arera goes a week, there may be some speculation about the matter.

"The way we doctors were disoriented with the newly-identified virus called Kovid-19 in March-April is no longer the case," he said. The most serious aspect of the character of the virus is paralysis of the lungs, so we had no special weapon in our hands except to rely on a ventilator at the beginning of the infection.

Ashok Sengupta said that after learning about the blood clots in the respiratory tract of the victims of the virus attack, the problem of shortness of breath is being largely prevented with blood thinners.

Arindam Biswas, a doctor of internal medicine in India, said, "People who do not have other chronic diseases and are younger, may have fever, cough and a little body, arm and leg pain as symptoms of Kovid-19 infection." But that doesn't mean we should take Corona lightly. "

He said Arindam Babu felt that a lot of research and data analysis was needed before he could say for sure whether the virus was losing power.

The doctor warned that if the power of the virus is reduced now, there will be a tendency among the common people not to follow the hygiene rules. This can lead to out-of-control infections.

"People who have co-morbidity, such as high blood pressure, diabetes, chronic kidney disease or heart disease, and are over 60 years of age, are at risk of contracting the virus and are at risk of death," said Arindam.

Kunal Sarkar said that as many epidemics or epidemics have taken place in the last one thousand years, at the beginning of its terrible power, people also died. But gradually the virus becomes somewhat weaker, again the human body develops some resistance against the virus. Although it is not yet time to say anything definite about it. But maybe the Novelcrona virus is about to reach that stage.

"Thousands of people were being infected and dying before doctors knew what to do at the beginning of the Covid-19 epilepsy," he said. That matter has largely diminished. We have some weapons to suppress the virus. At the same time, the virus is changing their character. '

Arindam believes, ‘People’s awareness about Corona has increased a lot from before. As a result, people go to the doctor as soon as they see few symptoms. In addition, due to the low load of the virus due to the use of masks, the symptoms of some people are not getting worse than the five viral fevers.

However, doctors agree that it is inappropriate to go anywhere without a mask or to increase the crowd because the power of the virus has decreased. It will be easier to prevent infections other than the novel coronavirus if you follow the rules of health such as washing your hands with soap and wearing a mask according to the rules
Coroner gave the good news about the vaccine

Coroner gave the good news about the vaccine

Corona virus has spread in the form of a global epidemic. Scientists all over the world are doing everything possible for an effective vaccine to get rid of this deadly virus. Yet a vaccine does not match.

However, researchers are optimistic about some vaccines. One of them is the vaccine from Oxford University in Britain. It is the most advanced of the hundreds of vaccines.

This time Oxford University gave good news about this vaccine. They said that if all goes well, their vaccine will be available in October. And the price of this tick will be equal to the price of just one cup of coffee.

Not just Oxford, but Pfizer, a US pharmaceutical company, gave such good news two days ago. The US company has claimed that they will also bring the vaccine in October.

But ahead is the Oxford Corona vaccine. Their vaccine is now in the third phase of experimental application. The outcome or effectiveness of the third phase of the vaccine will be known by the end of August. Regulators will approve the vaccine for emergency use only if evidence of success is found in the test. That means high-risk patients will get the vaccine by October.

Kate Binham, chairman of the UK Vaccine Task Force, said Oxford was far ahead in vaccine development. Other vaccines may begin vaccinating Oxford long before their effectiveness is tested.

AstraZeneca, a British pharmaceutical company, is already building a supply chain to quickly deliver the Oxford vaccine internationally. Officials at the company say they have already received orders for 200 million doses of the vaccine. The cost of each dose of vaccine can be equal to the price of one cup of coffee.

AstraZeneca chief executive Pascal Sariot said their vaccine would be able to protect against Covid-19 for up to a year. If all goes well, the vaccine supply will start in October.

But ahead is the Oxford Corona vaccine. Their vaccine is now in the third phase of experimental application. The outcome or effectiveness of the third phase of the vaccine will be known by the end of August. Regulators will approve the vaccine for emergency use only if evidence of success is found in the test. That means high-risk patients will get the vaccine by October.

Kate Binham, chairman of the UK Vaccine Task Force, said Oxford was far ahead in vaccine development. Other vaccines may begin vaccinating Oxford long before their effectiveness is tested.

AstraZeneca, a British pharmaceutical company, is already building a supply chain to quickly deliver the Oxford vaccine internationally. Officials at the company say they have already received orders for 200 million doses of the vaccine. The cost of each dose of vaccine can be equal to the price of one cup of coffee.

AstraZeneca chief executive Pascal Sariot said their vaccine would be able to protect against Covid-19 for up to a year. If all goes well, the vaccine supply will start in October.

No more worries about the corona virus

No more worries about the corona virus

The competition for the vaccine against coronavirus is now in full swing. Discussions have also started on which company will bring the vaccine first. However, experts say that in order to decide how and when to bring the vaccine, various factors such as the safe side and effectiveness of the vaccine should be taken into consideration.
The University of Oxford in England is well ahead in the race to develop a potential vaccine. Top scientists at the World Health Organization have also cited the Oxford vaccine as a pioneer. The price will be affordable. The results of the third phase of the Oxford-made vaccine will be known by the end of August, according to a report in the British magazine The Economist. Whether the vaccine will protect against the 12 million people infected with the coronavirus worldwide depends on the results of the test.
The Economist says that once the test is successful, regulators will approve the vaccine for emergency use. In other words, those who are high risk patients will get the vaccine by October.
According to Australia's News.com.au, the British pharmaceutical company AstraZeneca is building a supply chain to supply the Oxford vaccine quickly and widely internationally. Officials at the company say the vaccine will need multiple tests to get full approval. Full approval could be obtained early next year.
British Prime Minister Boris Johnson described the vaccine competition as the most important partnership effort of our lives. Researchers at Oxford, led by Professor Sarah Gilbert, developed a vaccine based on a drug that had previously been effective in treating similar viruses. They have quickly begun large-scale human testing. Kate Binham, chairman of the UK Vaccine Task Force, said Oxford was far ahead in vaccine development. Other vaccines may begin vaccinating Oxford long before their effectiveness is tested.
AstraZeneca says they have already received orders for 200 million doses of the vaccine. The cost of each dose of vaccine can be equal to the price of one cup of coffee. AstraZeneca chief executive Pascal Sariot said their vaccine would be able to protect against Covid-19 for up to a year. If all goes well, the results will be known in August or September. Vaccine production continues as well as waiting for the vaccine to bear fruit. If all goes well, the vaccine supply can start in October.

Wednesday, 24 June 2020

মন্ত্রিসভা প্রধানমন্ত্রীকে ইউএনপিএসএ পুরস্কার জেতার জন্য অভিনন্দন জানিয়েছেন মন্ত্রিপরিষদ

মন্ত্রিসভা প্রধানমন্ত্রীকে ইউএনপিএসএ পুরস্কার জেতার জন্য অভিনন্দন জানিয়েছেন মন্ত্রিপরিষদ

মন্ত্রিসভা প্রধানমন্ত্রীকে ইউএনপিএসএ পুরস্কার জেতার জন্য অভিনন্দন জানিয়েছেন মন্ত্রিপরিষদ


   মন্ত্রিপরিষদ প্রধানমন্ত্রী শেখ হাসিনাকে অভিনন্দন জানিয়ে একটি প্রস্তাব গৃহীত হয়েছে যেহেতু বাংলাদেশ "উন্নয়নশীল স্বচ্ছ ও জবাবদিহি প্রতিষ্ঠানসমূহ" বিভাগে মর্যাদাপূর্ণ জাতিসংঘ পাবলিক সার্ভিস অ্যাওয়ার্ড ২০২০ (ইউএনপিএসএ ২০২০) অর্জন করেছে।

 বুধবার এক হ্যান্ডআউটে জানানো হয়েছে, ৮ জুন মন্ত্রিপরিষদের বৈঠকে এই সম্মাননা প্রস্তাব গৃহীত হয়েছিল, এবং মন্ত্রিপরিষদ বিভাগ ১৫ ই জুন এ সংক্রান্ত একটি গেজেট প্রজ্ঞাপন জারি করেছে, বুধবার এক হ্যান্ডআউট জানায়।

 ভূমি মন্ত্রকের ই-মিউটেশন প্রোগ্রাম সফলভাবে বাস্তবায়নের জন্য বাংলাদেশ ইউএনপিএসএ ২০২০ জিতেছে।

 ২০২০ সালের ১ জুন, অর্থনৈতিক ও সামাজিক বিষয়ক বিষয়ক উপ-সেক্রেটারি-জেনারেল লিউ ঝেনমিন জাতিসংঘের রাষ্ট্রদূত রাবাব ফাতিমাকে বাংলাদেশ স্থায়ী প্রতিনিধিকে জাতিসংঘের পুরষ্কার জয়ের বিষয়ে অবহিত করেছিলেন।

 জাতিসংঘের আন্ডার সেক্রেটারি জেনারেল বলেছেন, ই-মিউটেশন প্রোগ্রামের বাস্তবায়ন বাংলাদেশের জন্য একটি উল্লেখযোগ্য অর্জন এবং এটি দেশের জন প্রশাসন প্রশাসনের উন্নয়নে গুরুত্বপূর্ণ ভূমিকা পালন করবে।

 বাংলাদেশ প্রথমবারের মতো মর্যাদাপূর্ণ ইউএন পুরষ্কার পেয়েছে।

 রেজুলেশন অনুসারে, মন্ত্রিপরিষদ বিশ্বাস করে যে প্রধানমন্ত্রী শেখ হাসিনার গতিশীল নেতৃত্ব, প্রজ্ঞা, দূরদর্শিতা এবং কার্যকর সিদ্ধান্তগুলি দেশে অভূতপূর্ব সাফল্য অর্জনে সহায়তা করেছে।

 "ডিজিটাল বাংলাদেশ" গড়ার দিকে তাঁর দূরদর্শী উদ্যোগের কারণে এই সম্মানজনক পুরষ্কার অর্জন সম্ভব হয়েছিল।

 প্রধানমন্ত্রী শেখ হাসিনার অক্লান্ত পরিশ্রম ও প্রত্যক্ষ তত্ত্বাবধানে গত দশ বছরে দেশের ভূমি ব্যবস্থাপনায় আমূল পরিবর্তন আনা হয়েছে।

 ই-মিউটেশনটি বর্তমান সরকারের ভিশন ২০২০ অর্জনে এবং ভূমি সেবার ক্ষেত্রে স্বচ্ছতা ও জবাবদিহিতা নিশ্চিত করে একটি ডিজিটাল বাংলাদেশ গঠনে গুরুত্বপূর্ণ ভূমিকা পালন করবে।

 তিন পার্বত্য জেলা বাদে সারা দেশে ই-মিউটেশন প্রয়োগ করা হচ্ছে।  আইসিটি বিভাগের এ ২ আই প্রকল্প এই লক্ষ্যে প্রযুক্তিগত সহায়তা প্রদান করে।

 ভূমি সংস্কার বোর্ডের পরিচালনায় সহকারী কমিশনার (ভূমি) এর মাধ্যমে এটি বাস্তবায়ন করা হচ্ছে।

Monday, 22 June 2020

Coronavirus: 'Life will live' in bed

Coronavirus: 'Life will live' in bed

A patient infected with Novel Coronavirus or Cavid-19 with severe respiratory distress was admitted to a hospital in New York, USA last Friday. The 40-year-old was in critical condition. Life support was in full swing. But with so many patients coming in, the pressure on the ICU continues to grow. Dr. Mangala Narasimhan then laid the patient on his back. This trick works like magic. After a while, the person began to breathe naturally. He no longer needed to be taken to the ICU.

According to a report by CNN Online, citing doctors treating people infected with coronavirus, if a person suffering from Covid-19 suffers from shortness of breath, he can be laid on his back to increase the supply of oxygen naturally. This method is called ‘prone positioning’.

Dr. Narasimhan said that this process works 100%. This is a very easy way. We see that the patient is improving tremendously.

Massachusetts General Hospital ICU Director. “You want to do the same thing over and over again when you see it working this way,” said Katherine Hibbert. And when a severe patient suffering from Covid-19 suffers from shortness of breath, lying on his back, it acts as a tonic.

Many patients with coronavirus suffer from severe shortness of breath. With this, if the person has pneumonia or any other complex disease, it becomes difficult to save him.

Seven years ago, a group of French doctors published a study in the New England Journal of Medicine. They showed that patients with shortness of breath who were placed on a ventilator had their chances of death greatly reduced by lying on their backs.

Doctors in the United States are already treating with this method. This method is now being used more in the country during the coronavirus epidemic.A New York hospital found that a coronavirus patient's oxygen supply increased from 85 percent to 96 percent after he was put to bed.

Patients who are on a ventilator are usually bedridden for 18 hours a day. Experts believe that it is easier for the patient to get oxygen if he is lying on his back. But when you lie down on your back, the supply of oxygen is interrupted